Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-017641
Filing Date
2016-05-04
Accepted
2016-05-04 16:06:13
Documents
45
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ttph-10q_20160331.htm 10-Q 1302121
2 EX-31.1 ttph-ex311_7.htm EX-31.1 17272
3 EX-31.2 ttph-ex312_6.htm EX-31.2 17318
4 EX-32.1 ttph-ex321_9.htm EX-32.1 6196
5 EX-32.2 ttph-ex322_8.htm EX-32.2 6209
  Complete submission text file 0001564590-16-017641.txt   4273795

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ttph-20160331.xml EX-101.INS 773505
7 XBRL TAXONOMY EXTENSION SCHEMA ttph-20160331.xsd EX-101.SCH 31469
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttph-20160331_cal.xml EX-101.CAL 26326
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttph-20160331_def.xml EX-101.DEF 105742
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttph-20160331_lab.xml EX-101.LAB 289890
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttph-20160331_pre.xml EX-101.PRE 210949
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35837 | Film No.: 161619304
SIC: 2834 Pharmaceutical Preparations